ADMA Biologics
Trade ADMA Biologics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ADMA
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center.
ADMA Key Statistics
Stock Snapshot
ADMA Biologics(ADMA) stock is priced at $9.13, giving the company a market capitalization of 2.14B. It carries a P/E multiple of 15.25.
As of 2026-03-31, ADMA Biologics(ADMA) stock has fluctuated between $8.95 and $9.42. The current price stands at $9.13, placing the stock +2.0% above today's low and -3.1% off the high.
ADMA Biologics(ADMA) shares are trading with a volume of 7.31M, against a daily average of 14.87M.
In the last year, ADMA Biologics(ADMA) shares hit a 52-week high of $25.67 and a 52-week low of $7.21.
In the last year, ADMA Biologics(ADMA) shares hit a 52-week high of $25.67 and a 52-week low of $7.21.
ADMA News
ADMA Biologics (ADMA) moved back into focus after its shares climbed about 11% following a detailed rebuttal to a short seller report that questioned ASCENIV de...
Vor Biopharma stock is among today’s top performers. What’s driving VOR stock higher? Vor Biopharma To Raise $75 Million Through Private Placement The clinical-...
The report from Culper Research, released on Tuesday, alleges that ADMA Biologics has been misrepresenting its financial results and operating metrics. The fir...
More ADMA News
The latest update is out from ADMA Biologics ( (ADMA) ). On March 27, 2026, ADMA Biologics issued a detailed rebuttal to a March 24, 2026 short-seller report f...
ADMA Biologics (NasdaqGM:ADMA) issued a public response to a short-seller report from Culper Research. The company disputed the accuracy of the allegations and...
Adma Biologics (ADMA) responded to a report issued on March 24 by short seller Culper Research. The company said, “Following a detailed review of the Short Repo...
ADMA Biologics, Inc. (NASDAQ:ADMA) shares are tumbling on Thursday after Cantor Fitzgerald downgraded the stock to Neutral. ADMA Biologics shares are approachin...
• ADMA Biologics stock is testing key support levels. What’s pressuring ADMA? Culper Research Describes ADMA Short; Alleges Misreporting The report from Culper...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.